#USA #New York #Securities Fraud #Pomerantz #Waldencast

Pomerantz Law Firm Investigates Claims Against Waldencast plc

Pomerantz LLP, a leading name in corporate and securities law, has initiated an investigation concerning claims made by investors of Waldencast plc (NASDAQ: WALD). This scrutiny comes in light of potential securities fraud and other unlawful business practices allegedly engaged in by the company and its executives. As Waldencast faces scrutiny from its shareholders, this development could have far-reaching implications for those who have invested in the firm, particularly following alarming news about its financial performance.

On November 24, 2025, Waldencast released its financial results for the second quarter of the year, which painted a grim picture of their fiscal health. Originally projecting mid-teens revenue growth, the company scaled back its expectations significantly, now predicting net revenues to align with the previous year's figures.

Furthermore, the adjusted EBITDA margin was adjusted down to high single digits from prior estimates in the mid-to-high teens, indicating substantial performance deterioration. Equally concerning, Waldencast disclosed a staggering net loss of $185.2 million for the first half of 2025. This loss was primarily attributed to hefty impairment charges totaling $132.1 million from its Obagi Medical brand, alongside $20 million impacting Milk Makeup.

The market responded negatively, evidenced by a 6.49% drop in Waldencast's Class A ordinary shares, which fell to $2.88 following the announcement. This decline illustrates investor apprehension regarding the company's future and the adequacy of its management practices.

Pomerantz Law Firm encourages investors who have suffered damages to come forward and share their experiences. Lead attorney Danielle Peyton is spearheading the investigation, and investors are advised to contact her directly for more information on possible class action participation. Pomerantz is known for advocating for victims of securities fraud and corporate misconduct, having recovered millions in damages for class members over its more than 85-year history.

This investigation opens a crucial chapter for Waldencast plc, especially for its investors who are seeking clarity and accountability amidst financial turbulence. In an environment where shareholder confidence is essential for market stability, the outcomes of such investigations can impact not just the involved companies but the broader market as well. Investors should remain vigilant and informed. For further assistance regarding this matter or to join the class action, individuals can contact the law firm at the provided details.

More information about Pomerantz Law Firm's commitment to defending investors can be obtained through their official website, where they emphasize a robust history in tackling securities class actions, thus maintaining their status as a pioneer in this field. As they delve deeper into the situation of Waldencast plc, stakeholders await further developments that could shape the future of their investments.